|
|
|
Posted on: Thursday, 15 May 2008, 18:00 CDT PhotoMedex, Inc. (NASDAQ: PHMD) today announced that, due to increased interest from viewers, its XTRAC® excimer laser segment, which first aired on Wednesday, May 7th, on The Balancing Act, an original, daily half-hour series for working women on...
Full Coverage:
PhotoMedex´s XTRAC(R) Excimer Laser Secures Additional Air Time on The LIFETIME Television´s ´´The..
PhotoMedex, Inc. (NASDAQ: PHMD) today announced that, due to increased interest from viewers, its XTRAC® excimer laser segment, which first aired on Wednesday, May 7th, on The Balancing Act, an original, daily half-hour series for working women on LIFETIME Television, will also air on Friday, May...
PhotoMedex obtains FDA approval for Xtrac Velocity Laser
PhotoMedex has received FDA 510k clearance to market the new, more powerful, faster Xtrac Velocity excimer laser system to treat psoriasis, vitiligo, atopic dermatitis and leukoderma. The Xtrac Velocity laser system is claimed to deliver the highest ultraviolet (UV) power of any medical excimer...
PhotoMedex shares rise; FDA approves XTRAC Velocity excimer laser system
NEW YORK (Thomson Financial) - Shares of PhotoMedex Inc. soared in afternoon trading Tuesday after the company said it received clearance from the Food and Drug Administration to market its XTRAC Velocity excimer laser system for the treatment of psoriasis, vitiligo, atopic dermatitis and...
FDA approves new PhotoMedex laser system
MONTGOMERYVILLE, Pa. (AP) - PhotoMedex Inc., which makes medical laser products and services, said Tuesday that it has received Food and Drug Administration clearance to market a new laser system to treat psoriasis and other skin conditions. PhotoMedex said the XTRAC Velocity laser system has a...
PhotoMedex Receives FDA Clearance for the XTRAC(R) Velocity(TM) Laser
PhotoMedex, Inc. (NASDAQ:PHMD), a leader in the development of proprietary excimer laser and fiber optic systems as well as techniques directed toward dermatological applications, today announced that it has received U.S. Food and Drug Administration 510k clearance to market the new, more...
PhotoMedex Receives Positive Reimbursement Decision From BlueCross BlueShield of Massachusetts...
Posted on: Tuesday, 13 May 2008, 12:00 CDT PhotoMedex, Inc. (NASDAQ:PHMD), a leader in the development of proprietary excimer laser and fiber optic systems as well as techniques directed toward dermatological applications, today announced that BlueCross BlueShield of Massachusetts has adopted a...
Related categories
International Editions
English - US | English - UK | Deutsch | Française | Español | Português | Italiano | Česká | Русский (Russian) | عربي (Arabic) | 中文（简）(Simplified Chinese)Copyright © 2008 Newstin a.s. All rights reserved. 4.2.5,fe-web-4.2.5;commons-4.2.1;api-4.2.1;fe-4.2.3, 10.10.1.27